Moderna refused China request to reveal vaccine technology – FT

Author of the article: Moderna Inc has refused to hand over to China the core intellectual property behind the development of its COVID-19 vaccine, leading to a collapse in negotiations on its sale there, the Financial Times reported on Saturday, citing people familiar with the matter. The Cambridge, Massachusetts-based pharmaceutical company turned down China’s request…
Moderna refused China request to reveal vaccine technology – FT

Author of the article:

Moderna Inc has refused to hand over to China the core intellectual property behind the development of its COVID-19 vaccine, leading to a collapse in negotiations on its sale there, the Financial Times reported on Saturday, citing people familiar with the matter.

The Cambridge, Massachusetts-based pharmaceutical company turned down China’s request to hand over the recipe for its mRNA vaccine because of commercial and safety concerns, the newspaper said, citing people involved in negotiations that took place between 2020 and 2021, adding that the vaccine maker is still “eager” to sell the product to China.

Financial Post Top Stories

Sign up to receive the daily top stories from the Financial Post, a division of Postmedia Network Inc.

By clicking on the sign up button you consent to receive the above newsletter from Postmedia Network Inc. You may unsubscribe any time by clicking on the unsubscribe link at the bottom of our emails. Postmedia Network Inc. | 365 Bloor Street East, Toronto, Ontario, M4W 3L4 | 416-383-2300

The company had “given up” on its previous efforts to access the Chinese market because of China’s demand that it hand over the technology as a prerequisite for selling in the country, the report said.

Moderna did not immediately respond to Reuters’ request for comment.

China has not approved any foreign COVID-19 vaccines and relies on several domestically developed shots.

In September, Moderna Chief Medical Officer Paul Burton had said the company was keen to collaborate with China on supplying its mRNA-based COVID-19 vaccines to the country.

“We would certainly be very eager to collaborate with China if they felt that there was a need for a vaccine there,” Burton had told a media briefing for reporters in Asia. “Currently, there is no activity going on, but we’d be very open to it.” (Reporting by Rhea Binoy in Bengaluru; editing by Jonathan Oatis)

Read More

Total
0
Shares
Leave a Reply

Your email address will not be published.

Related Posts
ECB Hikes Add Mortgage Agony to 20% Inflation at Euro Zone’s Eastern Edge
Read More

ECB Hikes Add Mortgage Agony to 20% Inflation at Euro Zone’s Eastern Edge

Sign up for the New Economy Daily newsletter, follow us @economics and subscribe to our podcast. Author of the article: Bloomberg News Aaron Eglitis, Ott Tammik and Milda Seputyte frrcmoc1(h9kkd3679phefll_media_dl_1.png Bloomberg RSS (Bloomberg) — Sign up for the New Economy Daily newsletter, follow us @economics and subscribe to our podcast. Advertisement 2 This advertisement has not loaded yet, but your article continues below.…
Ethiopia hosts UN internet meeting after cutting off Tigray
Read More

Ethiopia hosts UN internet meeting after cutting off Tigray

Author of the article: The Associated Press Jamey Keaten And Cara Anna GENEVA (AP) — A U.N. body devoted to promoting broader and better access to the internet is about to hold its annual meeting in Ethiopia, whose government has cut off internet access in its northern Tigray region during a two-year war there. Critics…
Authentic Brands withdraws IPO plans
Read More

Authentic Brands withdraws IPO plans

Author of the article: Apparel chain operator Authentic Brands Group on Wednesday filed to withdraw its plans for an initial public offering in the United States. (Reporting by Manya Saini in Bengaluru; Editing by Shailesh Kuber) Advertisement This advertisement has not loaded yet, but your article continues below. Financial Post Top Stories Sign up to…